DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ce161d/us_insulin_deliver) has announced the addition of the "US Insulin Delivery Devices Market: An Analysis" report to their offering.
Diabetes currently affects around 25.8 million children and adults in the United States which is approximately 8.3 per cent of the population, and is expected to affect more than half of the population by 2020. Key factors responsible for the rising prevalence of diabetes are the sedentary lifestyle, unhealthy diet and increasing incidence of obesity in the country. Rising concerns towards healthcare and increasing per capita income of the individuals has made insulin devices such as insulin pump, pens etc. affordable for the individuals. Amid all these factors, US has emerged as the biggest insulin delivery devices market in the world and is anticipated to witness double digit growth in the coming years.
The report titled US Insulin Delivery Devices Market: An Analysis provides a succinct but deep dive analysis of the current status and overall growth prospects of the US insulin delivery device market. The report gives an insight into the various trends and developments that are currently taking place in the market and substantiates data with necessary statistics. The growth in the market has been studied by categorizing it into four components: Insulin pumps, Insulin pens, Insulin syringes and insulin jet injectors. Key findings in the report include:
1. In US, of the total diabetic population, 10 per cent are Type I diabetic patients. Annually, US spends more than USD 14 billion for the treatment of Type I diabetes which poses burden on the government authorities.
2. Approximately 400,000 of the 3 million people in the United States with Type I diabetes use insulin pumps. As a result of such high penetration of insulin pumps, US lead the insulin pump market globally.
3. The main driver of growth in the industry is the strategic collaborations taking place. Several companies in US are collaborating with the domestic research institutes and vendors in order to build more advance and efficient insulin delivery systems.
Key Topics Covered:
1. Research Methodology
2. US Insulin Market: An Introduction
3. US Insulin Delivery Devices Market: An Overview
4. Key Market Trends and Drivers
5. Components of Insulin Delivery Devices Market
6. Regulatory Framework
7. Key Players
8. Conclusion
Companies Mentioned:
- Novo Nordisk,
- Eli Lily,
- Becton Dickinson,
- Medtronic,
- Sanofi Aventis
For more information visit http://www.researchandmarkets.com/research/ce161d/us_insulin_deliver